Publication date: Jul 24, 2024
The development, manufacture, and deployment of new vaccine technologies to combat SARS-CoV-2 enabled an unparalleled rapid response to the emerging health threat. However, the unequal global distribution of these vaccines highlighted a major gap in existing thermotolerance profiles and cold chain infrastructure that needs to be addressed to maximize their global health impact.
| Concepts | Keywords |
|---|---|
| Global | COVID-19 |
| Profiles | COVID-19 Vaccines |
| Thermostability | COVID-19 Vaccines |
| Unparalleled | Health Equity |
| Vaccine | Humans |
| SARS-CoV-2 | |
| Temperature |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | VO | vaccine |
| disease | VO | Equity |
| disease | VO | Gap |
| disease | MESH | COVID-19 |
Original Article
(Visited 1 times, 1 visits today)